menu
    • menu
    [{"orgOrder":0,"company":"Taiho Pharmaceutical","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"JAPAN","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"TAS-118","moa":"Dihydrofolate reductase\/Thymidylate synthase","graph1":"Oncology","graph2":"Phase III","graph3":"Taiho Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Taiho Pharmaceutical \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"10","companyTruncated":"Taiho Pharmaceutical \/ YAKULT HONSHA CO LTD"}]

    Find Clinical Drug Pipeline Developments & Deals for TAS-118

    Menu

    TAS-118

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Taiho Pharmaceutical

                            Japan arrow
                            CTAD25
                            Not Confirmed

                            Taiho Pharmaceutical

                            Japan arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : TAS-118

                            Therapeutic Area : Oncology

                            Study Phase : Phase III

                            Sponsor : YAKULT HONSHA CO LTD

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer

                            Details : TAS-118 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Stomach Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            December 23, 2014

                            Lead Product(s) : TAS-118

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase III

                            Sponsor : YAKULT HONSHA CO LTD

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth